advanced malignant tumor

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Tumor Trial (SHR-5495 for injection)

Not yet recruiting
  • Advanced Malignant Tumor
  • SHR-5495 for injection
  • (no location specified)
Sep 26, 2023

Advanced Malignant Tumor Trial in Jinan (JS207)

Not yet recruiting
  • Advanced Malignant Tumor
  • Jinan, Shandong, China
    Affiliated Cancer Hospital of Shandong First Medical University
Aug 28, 2023

Advanced Malignant Tumor Trial (HRS-2189 Tablets)

Not yet recruiting
  • Advanced Malignant Tumor
  • HRS-2189 Tablets
  • (no location specified)
May 6, 2023

Advanced Malignant Tumor Trial in Guangzhou (BAT7104 injection)

Recruiting
  • Advanced Malignant Tumor
  • BAT7104 injection
  • Guangzhou, Guangdong, China
    Li Zhang
Mar 1, 2023

Advanced Malignant Tumor Trial in Zhengzhou (HRS2398 Tablets)

Recruiting
  • Advanced Malignant Tumor
  • HRS2398 Tablets
  • Zhengzhou, Henan, China
    Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer
Aug 2, 2022

Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)

Recruiting
  • Advanced Malignant Tumor
  • TQB3915 tablets
  • Guangzhou, Guangdong, China
  • +2 more
Jun 9, 2022

Advanced Malignant Tumor Trial (HRS7415)

Not yet recruiting
  • Advanced Malignant Tumor
  • (no location specified)
Apr 1, 2022

Advanced Malignant Tumor Trial in Nanjing, Tianjin (TQB3909 Tablets)

Recruiting
  • Advanced Malignant Tumor
  • TQB3909 Tablets
  • Nanjing, Jiangsu, China
  • +1 more
Mar 3, 2022

Advanced Malignant Tumor Trial (Mitoxantrone Hydrochloride Liposome)

Not yet recruiting
  • Advanced Malignant Tumor
  • Mitoxantrone Hydrochloride Liposome
  • (no location specified)
Oct 9, 2021

Advanced Malignant Tumor Trial in Nanjing (QLS31901)

Recruiting
  • Advanced Malignant Tumor
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2021

Advanced Malignant Tumor Trial in Guangzhou (SH3765 tablet)

Not yet recruiting
  • Advanced Malignant Tumor
  • SH3765 tablet
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 18, 2021

Advanced Malignant Tumor Trial in Shanghai (Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant

Recruiting
  • Advanced Malignant Tumor
  • Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection (CDP1)
  • Shanghai, Shanghai, China
    Dragonboat Biopharmaceutical,Co.,Ltd
Feb 3, 2021

Advanced Malignant Tumor Trial in Shanghai, Chengdu (QL1604)

Unknown status
  • Advanced Malignant Tumor
  • Shanghai, Shanghai, China
  • +1 more
Mar 26, 2020

Advanced Malignant Tumor Trial in Guangzhou (QL1706)

Unknown status
  • Advanced Malignant Tumor
  • QL1706
  • Guangzhou, Guangdong, China
    Sun Yat-sen Univeisity Cancer Center
Mar 3, 2020